Microneedle Drug Delivery Systems Market To Reach $9.46 Billion By 2030

Microneedle Drug Delivery Systems Market Growth & Trends

The global microneedle drug delivery systems market size is estimated to reach USD 9.46 billion by 2030, registering a CAGR of 7.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing demand for safer alternatives to conventional hypodermic injection and increasing awareness about minimally invasive and pain-free administration of drugs is expected to boost the market growth for microneedle drug delivery systems. Furthermore, increasing cases of diabetes are also expected to boost the market growth. For instance, as per the estimates of the World Health Organization (WHO) in 2021, approximately 463 million adults were living with diabetes, worldwide, representing 9.3% of the global population.

Microneedles offer several advantages over traditional drug delivery methods, such as oral or transdermal routes. Studies have shown that drug delivery by microneedles can improve drug absorption, bioavailability and efficacy, especially for drugs with poor water solubility or low permeability. For instance, a study published in "Journal of Controlled Release" showed that transdermal delivery of insulin using microneedles was more effective than subcutaneous injection.

The COVID-19 pandemic had a significant impact on drug delivery by microneedles. The major impact of the pandemic on the market was the increased demand for vaccine delivery. Microneedles have been explored as a potential delivery method for the COVID-19 vaccines due to their ease of use, low cost, and potential to induce a strong immune response. The pandemic has accelerated development of the microneedle-based vaccine delivery systems, with several companies and academic institutions working on COVID-19 vaccine patches.

However, the pandemic has also disrupted global supply chains, which has affected the production and distribution of microneedle-based drug delivery systems. Some manufacturers have faced challenges in obtaining raw materials and components, which has resulted in supply shortages and increased prices.

 Request a free sample copy or view report summary: Microneedle Drug Delivery Systems Market Report

Microneedle Drug Delivery Systems Market Report Highlights

• By type, the hollow microneedle segment accounted for the largest revenue share in 2024, since they are considered ideal for the use of vaccine and hormonal therapy patients

• Dissolving microneedle type segment is expected to grow at the fastest CAGR during the forecast period, as it only requires one step, the microneedle needs not be removed after insertion

• Based on material, the metal segment accounted for the highest revenue share in 2024, stainless steel and titanium are the most frequently employed metals

• The drug delivery application segment held the largest market share of 34.3% in 2024, due to the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular conditions

• The vaccine delivery segment is expected to experience the fastest CAGR during the forecast period, due to the increased awareness of vaccination among populations

• Asia Pacific is anticipated to grow at the fastest CAGR during the forecast period, due to the presence of untapped opportunities in the emerging economies of China and India.

Microneedle Drug Delivery Systems Market Segmentation

Grand View Research has segmented the global microneedle drug delivery systems market based on type, material, application, and region:

Microneedle Drug Delivery Systems Type Outlook (Revenue, USD Million, 2018 - 2030)

• Hollow

• Solid

• Coated

• Dissolving

• Others

Microneedle Drug Delivery Systems Material Outlook (Revenue, USD Million, 2018 - 2030)

• Metal

• Silicon

• Polymer

• Others

Microneedle Drug Delivery Systems Application Outlook (Revenue, USD Million, 2018 - 2030)

• Drug Delivery

• Vaccine Delivery

• Pain Management

• Cancer Therapy

• Dermatology

• Others

Microneedle Drug Delivery Systems Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Microneedle Drug Delivery Systems Market

• Raphas Co., Ltd.

• Novartis AG

• BD

• B. Braun SE

• NanoPass

• Terumo Corporation

• Smiths Group plc

• Cardinal Health

• 3M